BENITEC BIOPHARMA INC (BNTC)
US08205P2092 - Common Stock
| MRQ (2023-12-31) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | 19.77M | 5.23M | |||
| Cash Equivalents | 20.37M | 2.48M | 4.06M | 0.00 | 4.57M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 53.00K | 60.00K | 0.00 | 30.00K | 60.00K | |||
| Other Current Assets | 369.00K | 1.19M | 760.00K | 810.00K | 950.00K | |||
| Total Current Assets | 20.80M | 3.73M | 4.82M | 20.61M | 10.81M | |||
| Non-Current Assets | ||||||||
| PPE Net | 451.00K | 610.00K | 990.00K | 580.00K | 770.00K | |||
| Investments And Advances | N/A | N/A | N/A | N/A | 10.00K | |||
| Other Non-Current Assets | 106.00K | 120.00K | 160.00K | 190.00K | 10.00K | |||
| Total Non-Current Assets | 557.00K | 730.00K | 1.15M | 770.00K | 780.00K | |||
| TOTAL ASSETS | 21.35M | 4.46M | 5.97M | 21.38M | 11.59M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 3.05M | 2.77M | 2.04M | 920.00K | 600.00K | |||
| Accounts Payable | 2.62M | 1.14M | 420.00K | 270.00K | 280.00K | |||
| Other Current Liabilities | 74.00K | 70.00K | 70.00K | 170.00K | 250.00K | |||
| Total Current Liabilities | 5.75M | 3.98M | 2.53M | 1.37M | 1.14M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 137.00K | 280.00K | 560.00K | 0.00 | 210.00K | |||
| Total Non-Current Liabilities | 137.00K | 280.00K | 560.00K | 0.00 | 210.00K | |||
| TOTAL LIABILITIES | 5.88M | 4.26M | 3.09M | 1.37M | 1.35M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -180.64M | -167.89M | -148.33M | -130.12M | -116.64M | |||
| Additional Paid In Capital | 197.06M | 168.92M | 152.45M | 151.58M | 128.83M | |||
| Common Shares | 260.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -952.26K | -830.00K | -1.25M | -1.46M | -1.95M | |||
| Shares Outstanding | 2.59M | 1.65M | 480.00K | 480.00K | 70.00K | |||
| Tangible Book Value per Share | 5.97 | 0.12 | 6.00 | 41.69 | 146.29 | |||
| Total Shareholders' Equity | 15.47M | 200.00K | 2.88M | 20.01M | 10.24M | |||
| TOTAL LIABILITIES AND EQUITY | 21.35M | 4.46M | 5.97M | 21.38M | 11.59M | |||
| Statistics | ||||||||
| Current Ratio | 3.62 | 0.94 | 1.91 | 15.04 | 9.48 | |||
| Return On Assets (ROA) | -102.15% | -438.57% | -305.03% | -64.92% | -71.35% | |||
| Return On Equity (ROE) | -141.00% | -9780.00% | -632.29% | -69.37% | -80.76% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD